HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation

被引:64
作者
Mercenne, Gaelle [1 ]
Bernacchi, Serena [1 ]
Richer, Delphine [1 ]
Bec, Guillaume [1 ]
Henriet, Simon [1 ]
Paillart, Jean-Christophe [1 ]
Marquet, Roland [1 ]
机构
[1] Univ Strasbourg, CNRS, IBMC, Architecture & Reactivite ARN, F-67084 Strasbourg, France
关键词
VIRUS TYPE-1 VIF; INFECTIVITY FACTOR VIF; ANTIVIRAL ACTIVITY; VIRAL INFECTIVITY; PRIMER TRNA(3)(LYS); ENZYME APOBEC3G; GENOMIC RNA; IN-VITRO; PROTEIN; DEGRADATION;
D O I
10.1093/nar/gkp1009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HIV-1 viral infectivity factor (Vif) allows productive infection of non-permissive cells (including most natural HIV-1 targets) by counteracting the cellular cytosine deaminases APOBEC-3G (hA3G) and hA3F. The Vif-induced degradation of these restriction factors by the proteasome has been extensively studied, but little is known about the translational repression of hA3G and hA3F by Vif, which has also been proposed to participate in Vif function. Here, we studied Vif binding to hA3G mRNA and its role in translational repression. Filter binding assays and fluorescence titration curves revealed that Vif tightly binds to hA3G mRNA. Vif overall binding affinity was higher for the 3'UTR than for the 5'UTR, even though this region contained at least one high affinity Vif binding site (apparent K-d = 27 +/- 6 nM). Several Vif binding sites were identified in 5' and 3'UTRs using RNase footprinting. In vitro translation evidenced that Vif inhibited hA3G translation by two mechanisms: a main time-independent process requiring the 5'UTR and an additional time-dependent, UTR-independent process. Results using a Vif protein mutated in the multimerization domain suggested that the molecular mechanism of translational control is more complicated than a simple physical blockage of scanning ribosomes.
引用
收藏
页码:633 / 646
页数:14
相关论文
共 38 条
[1]   Advances in the structural understanding of Vif proteins [J].
Barraud, Pierre ;
Paillart, Jean-Christophe ;
Marquet, Roland ;
Tisne, Carine .
CURRENT HIV RESEARCH, 2008, 6 (02) :91-99
[2]   RNA and DNA binding properties of HIV-1 vif protein - A fluorescence study [J].
Bernacchi, Serena ;
Henriet, Simon ;
Dumas, Philippe ;
Paillart, Jean-Christophe ;
Marquet, Roland .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (36) :26361-26368
[3]   Role of 5′- and 3′-untranslated regions of mRNAs in human diseases [J].
Chatterjee, Sangeeta ;
Pal, Jayanta K. .
BIOLOGY OF THE CELL, 2009, 101 (05) :251-262
[4]   The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements [J].
Chiu, Ya-Lin ;
Greene, Warner C. .
ANNUAL REVIEW OF IMMUNOLOGY, 2008, 26 :317-353
[5]   The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G [J].
Conticello, SG ;
Harris, RS ;
Neuberger, MS .
CURRENT BIOLOGY, 2003, 13 (22) :2009-2013
[6]   Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription [J].
Henriet, S. ;
Sinck, L. ;
Bec, G. ;
Gorelick, R. J. ;
Marquet, R. ;
Paillart, J.-C. .
NUCLEIC ACIDS RESEARCH, 2007, 35 (15) :5141-5153
[7]   Cooperative and specific bindig of Vif to the 5′ region of HIV-1 genomic RNA [J].
Henriet, S ;
Richer, D ;
Bernacchi, S ;
Decroly, E ;
Vigne, R ;
Ehresmann, B ;
Ehresmann, C ;
Paillart, JC ;
Marquet, R .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 354 (01) :55-72
[8]   Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors [J].
Henriet, Simon ;
Mercenne, Gaelle ;
Bernacchi, Serena ;
Paillart, Jean-Christophe ;
Marquet, Roland .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2009, 73 (02) :211-232
[9]   APOBEC-mediated viral restriction: not simply editing? [J].
Holmes, Rebecca K. ;
Malim, Michael H. ;
Bishop, Kate N. .
TRENDS IN BIOCHEMICAL SCIENCES, 2007, 32 (03) :118-128
[10]   An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 [J].
Jarmuz, A ;
Chester, A ;
Bayliss, J ;
Gisbourne, J ;
Dunham, I ;
Scott, J ;
Navaratnam, N .
GENOMICS, 2002, 79 (03) :285-296